The distribution of tumour classes (TNM classification), clinical stages, tumour grades and the histological subtype of the RCC in comparison to the immunostaining pattern for myosin VI, beta-catenin and E-cadherin are described in Table 1, Table 2 and Table 3, respectively. Here, MYO6 is linked to renal cell carcinoma.